During the past decade, Rebecca and John Moores UCSD Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 29 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rebecca and John Moores UCSD Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 43 trials, followed by "Children's Oncology Group" with 22 trials sponsored, "Radiation Therapy Oncology Group" with 11 trials sponsored, "AIDS Malignancy Consortium" with 8 trials sponsored and "SWOG Cancer Research Network" with 8 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rebecca and John Moores UCSD Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 111 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "The Emmes Company, LLC" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Rebecca and John Moores UCSD Cancer Center" are "Lymphoma" (20 trials), "Breast Cancer" (14 trials), "Leukemia" (14 trials), "Lung Cancer" (13 trials) and "Sarcoma" (9 trials). Many other conditions were trialed in "Rebecca and John Moores UCSD Cancer Center" in a lesser frequency.

Most popular intervention types in "Rebecca and John Moores UCSD Cancer Center" are "Drug" (98 trials), "Biological" (38 trials), "Radiation" (27 trials), "Procedure" (26 trials) and "Other" (14 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (21 trials), "filgrastim" (18 trials), "radiation therapy" (16 trials), "etoposide" (14 trials) and "carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Rebecca and John Moores UCSD Cancer Center" are 96 trials for "All" genders, 14 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Rebecca and John Moores UCSD Cancer Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in Rebecca and John Moores UCSD Cancer Center, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Rebecca and John Moores UCSD Cancer Center, 14 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".